Read + Share
Amedeo Smart
Independent Medical Education
Walsh CS, Kamrava M, Rogatko A, Kim S, et al. Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer. PLoS One 2021;16:e0252665.PMID: 34081738
Email
LinkedIn
Facebook
Twitter
Privacy Policy